The filing is a surprise loss of a divisional leader, not a scheduled succession. Vivek Jetley, President and Head of Insurance, Healthcare and Life Sciences, notified the company of his intention to resign effective October 26, 2026. 〔0〕
The immediate risk is execution disruption across three strategically important businesses. The filing does not quantify revenue or earnings exposure, and it provides no indication that clients, targets, or financial guidance are changing. Jetley will remain through the effective date to support an orderly transition. 〔1〕
The company’s mitigation is continuity through its existing management team, but no successor is named. After October 26, Jetley’s responsibilities will be assumed by other members of management rather than by a disclosed replacement. 〔2〕
Net read: mildly worse than the standing expectation of leadership continuity. The absence of a stated disagreement, the transition period, and the lack of any disclosed financial change limit the severity; nevertheless, an unplanned departure from a senior executive overseeing Insurance, Healthcare and Life Sciences is a modest negative until the company clarifies succession and operating impact. 〔3〕
Read the original 8-K on SEC EDGAR ↗